| EudraCT Number |
Preparation |
Short title, Indication |
| 2005 |
| 2005-000774-46 |
BM, autologous |
BOOST-2, myocardial regeneration |
| 2005-000968-33 |
BM, autologous |
PROVASA, chronic limb ischemia [27] |
| 2005-000969-19 |
BM, autologous |
RENERVATE, diabetic neuropathy |
| 2005-003629-19 |
BM, autologous |
Myocardial regeneration |
| 2006 |
| 2005-005709-50 |
BM, autologous |
CELLWAVE, Combined Extra corporal Shock Wave Therapy and Intracoronary Cell Therapy in Chronic Ischemic Myocardium |
| 2005-004051-35 |
BM, autologous, CD133+ |
INSTEM, myocardial regeneration, combined with Trans Myocardial Laser Revascularisation (TMLR) |
| 2006-000393-76 |
PB, allogeneic, CD3/CD19 depleted |
Hematological disorders in pediatric patients |
| 2005-004028-38 |
BM, autologous, CD133+ |
Chronic cardiac ischemia |
| 2007 |
| 2006-006404-11 |
PB, autologous, CD133+ |
PERFECT, Intramyocardial transplantation for Improvement of Post-Infarct Myocardial Regeneration in Addition to Surgery |
| 2007-004874-14 |
BM, autologous |
REPAIR,Reinfusion of Enriched Progenitor cells And Infarct Remodeling in non-ST elevation AMl |
| 2008 |
| 2007-007694-23 |
CB, autologous |
Umbilical cord blood to reverse DM type I in children |
| 2006-001269-40 |
PB, autologous, CD34+ |
Severe lupus erythematodes |
| 2007-006016-33 |
PB, allogeneic, CD3/CD19 depletion |
Reduced conditioning in adult leukemia patients |
| 2008-004625-42 |
BM, autologous |
AMI; intramyocardial application |
| 2007-003514-34 |
PB, allogeneic |
Comparing chemotherapy with stem cell transplantation in elderly with AML |
| 2008-003658-13 |
PB, autologous |
EWING 2008; Ewing sarcoma, chemotherapy versus chemotherapy + HPC |
| 2009 |
| 2008-008368-28 |
BM, autologous |
Ischemic cardiomyopathy, intramyocardial application |
| 2007-004517-34 |
PB, allogeneic, CD3/CD19 depletion |
Relapsed or refractory AML (including children) |
| 2010 |
| 2009-013856-61 |
PB, autologous |
multiple myeloma; combined with lenalidomid/dexamehtason |
| 2010-019377-15 |
BM or PB, allogeneic |
AML; allogeneic HPC versus chemotherapy |
| 2008-001669-27 |
PB, allogeneic |
Poor-risk CLL |
| 2010-018467-42 |
PB, allogeneic |
MDS; 5-Azacytidine versus 5-Azacytidine + allogeneic HPC |
AMI: Acute Myocardial Infarction; AML: Acute Myeloid Leukemia; CLL: Chronic Lymphatic Leukemia; DM: Diabetes mellitus; MDS: Myelo Dysplastic Syndrome. |
